Inventor · disambiguated record
Atsushi Endo
Also filed as: ENDO ATSUSHI
30 granted patents·10 pending applications·480 citations·filing 2006–2025
97Inventor score
Top patents by PatentIndex Score
40 records- 0199US9382262B2Compounds useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2014·Granted Jul 5, 2016·39 cites·9 claims
- 0299US8350067B2Compounds useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2012·Granted Jan 8, 2013·64 cites·13 claims
- 0398US9856276B2Compounds useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2016·Granted Jan 2, 2018·15 cites·12 claims
- 0498US9802953B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 31, 2017·15 cites·2 claims
- 0598US8927597B2Compounds useful in the synthesis of halichondrin B analogsENDO ATSUSHI·Filed 2013·Granted Jan 6, 2015·47 cites·28 claims
- 0697US10214539B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2017·Granted Feb 26, 2019·11 cites·4 claims
- 0797US9604993B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2015·Granted Mar 28, 2017·16 cites·11 claims
- 0897US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 0997US8987479B2Intermediates and methods for the synthesis of halichondrin B analogsCHASE CHARLES·Filed 2011·Granted Mar 24, 2015·46 cites·10 claims
- 1097US8203010B2Compounds useful in the synthesis of halichondrin B analogsENDO ATSUSHI·Filed 2011·Granted Jun 19, 2012·57 cites·11 claims
- 1196US8093410B2Intermediates and methods for the synthesis of halichondrin B analogsCHASE CHARLES·Filed 2008·Granted Jan 10, 2012·68 cites·39 claims
- 1295US10494388B2Compounds useful in the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2017·Granted Dec 3, 2019·7 cites·26 claims
- 1393US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 1490US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 1589US10717743B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2019·Granted Jul 21, 2020·2 cites·8 claims
- 1687US10246480B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Apr 2, 2019·5 cites·30 claims
- 1786US10836784B2Substituted phosphorodiamidate morpholino oligomersEISAI R&D MAN CO LTD·Filed 2019·Granted Nov 17, 2020·2 cites·6 claims
- 1886US10457698B2Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomersEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 29, 2019·4 cites·4 claims
- 1983US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 2083US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 2182US2025171475A1Chiral reagents for preparation of homogeneous oligomersEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2274US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2372US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 2470US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 2569US11339188B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2020·Granted May 24, 2022·0 cites·18 claims
- 2667US9663486B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 2767US2021171555A1Chiral reagents for preparation of homogeneous oligomersEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 2867US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 2964US2018354939A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 3062US10618930B2Compounds for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Apr 14, 2020·0 cites·18 claims
- 3162USRE47193ESelectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Jan 8, 2019·0 cites·32 claims
- 3262US10087174B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted Oct 2, 2018·0 cites·17 claims
- 3360US2016326161A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2016·Application pending·0 cites
- 3458US2020055883A1Cyclic di-nucleotides derivative for the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 3557US2020361915A1Solid state form of pladienolide pyridine compounds and methods of useEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 3657US2024383940A1Synthesis of trinucleotide and tetranucleotide caps for mrna productionMODERNA TX INC·Filed 2022·Application pending·0 cites
- 3756US10745387B2Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereofEISAI R&D MAN CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·26 claims
- 3854US12251394B2Methods for the treatment of bladder cancerEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 18, 2025·0 cites·12 claims
- 3948US2006287520A1Synthesis of salinosporamide A and analogues thereofDANISHEFSKY SAMUEL J·Filed 2006·Application pending·0 cites
- 4042US11136335B2Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereofEISAI R&D MAN CO LTD·Filed 2017·Granted Oct 5, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Atsushi Endo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →